Health tech startup HealthKart has raised $135 million in a funding round led by Temasek, along with the participation from A91 Partners and Kae Capital.
According to HealthKart, the raised capital will be used to build its direct-to-consumer (D2C) brands, increase its offline distribution, expand international operations, and acquisitions.
Last fortnight, the startup raised $65 million in a funding round from Temasek with the participation of A91 Partners, according to its regulatory filings.
Founded in 2011 by Sameer Maheshwari and Prashant Tandon, Healthkart offers a variety of fitness products and services to help consumers achieve their fitness goals. The startup sells a wide range of healthcare products, including nutrition supplements, diabetes supplies, home medical devices, and baby care items.
HealthKart, which is run by Bright Lifecare Pvt. Ltd, makes supplement brands such as MuscleBlaze, The Protein Zone, TrueBasics, HKVitals, bGreen, Nouriza and Gritzo.
“We are delighted to partner with Temasek and A91 Partners in our mission to deliver innovative, high quality, yet affordable preventive care solutions to Indian consumers. Driving fitness and preventive health by addressing the nutritional gaps is a systemic trend which is taking off in a big way in India. With HealthKart’s R&D capabilities and omni-channel distribution infrastructure, we are excited to lead the way,” said Sameer Maheshwari, Co-Founder & CEO of Healthkart.
“HealthKart is best positioned to capitalise on the massive opportunity ahead. It has been a privilege to partner with them on one of the largest transactions in the Healthcare and D2C vertical,” said Neeraj Shrimali, Executive Director, Digital & Technology Investment Banking at Avendus Capital.
